Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Onsdag 28 Oktober | 18:13:15 Europe / Stockholm

Svenska | English

Investor Relations

Public Relations

Redeye

Bifogade filer

Redeye Initiates Coverage of SenzaGen

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Redeye Initiates Coverage of SenzaGen

2022-05-05 07:40:00

Redeye initiates coverage of SenzaGen, a Swedish commercial-stage MedTech company offering high-performance in-vitro technology tests that are set to capitalize on the trend toward animal-free testing in cosmetics, medical devices, chemicals, and pharmaceutical industries. Its updated growth-oriented commercial strategy, driven by an increased effort for acquisitions, offers a compelling case with 63% upside to our Base Case.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/